Literature DB >> 1690208

Cooperative trials of Hodgkin's lymphoma in the Federal Republic of Germany.

V Diehl1, M Pfreundschuh, M Löffler, U Rühl, E Hiller, H Gerhartz, H Kirchner.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1990        PMID： 1690208     DOI： 10.1007/bf01612650

Source DB:  PubMed          Journal:  J Cancer Res Clin Oncol        ISSN： 0171-5216            Impact factor:   4.553


× No keyword cloud information.
  3 in total

Review 1.  [Therapy of recurrent Hodgkin's lymphoma. II. The value of bone marrow transplantation].

Authors:  M Pfreundschuh; V Diehl
Journal:  Dtsch Med Wochenschr       Date:  1989-06-09       Impact factor: 0.628

2.  Lomustine, etoposide, vindesine, and dexamethasone (CEVD) in Hodgkin's lymphoma refractory to cyclophosphamide, vincristine, procarbazine, and prednisone (COPP) and doxorubicin, bleomycin, vinblastine, and dacarbazine (ABVD): a multicenter trial of the German Hodgkin Study Group.

Authors:  M G Pfreundschuh; W D Schoppe; R Fuchs; K H Pflüger; M Loeffler; V Diehl
Journal:  Cancer Treat Rep       Date:  1987-12

3.  Chemotherapy of Hodgkin's lymphoma with alternating cycles of COPP (cyclophosphamide, vincristin, procarbazine, prednisone) and ABVD (doxorubicin, bleomycin, vinblastine and dacarbazine). Results of the HD1 and HD3 trials of the German Hodgkin Study Group.

Authors:  V Diehl; M Pfreundschuh; M Löffler; U Rühl; E Hiller; H Gerhartz; W Wilmanns; H Kirchner; W Schoppe; S Petsch
Journal:  Med Oncol Tumor Pharmacother       Date:  1989
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.